Chief Scientific Officer
Current
Mar 2023 - Present
AeroLeads people directory · profile
Christopher Bond Email & Phone Number
CSO at Notch Therapeutics
at
Notch Therapeutics
1 work email found
@notchtx.com
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
CSO at Notch Therapeutics
Location
Seattle, Washington, United States
Who is Christopher Bond? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Christopher Bond is listed as CSO at Notch Therapeutics at Notch Therapeutics, based in Seattle, Washington, United States. AeroLeads shows a work email signal at notchtx.com and a matched LinkedIn profile for Christopher Bond.
Christopher Bond previously worked as Chief Scientific Officer at Notch Therapeutics and SVP Research and Early Development at Notch Therapeutics. Christopher Bond holds Ph.D., Biochemistry from University Of Washington.
Company email context
Email format at Notch Therapeutics
This section adds company-level context without repeating Christopher Bond's masked contact details.
{first_initial}{last}@notchtx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Christopher Bond. Compare company email patterns before reaching out.
Profile bio
About Christopher Bond
Experienced executive with a demonstrated history of leading successful teams in the development of new therapies in oncology. Skilled in CAR-T and T-Cell therapies, Antibodies, Protein Chemistry, Molecular Biology, CRISPR gene editing, and Biotechnology. Strong industry and academic background with a Ph.D. in Biochemistry from University of Washington.
Listed skills include Antibodies, Protein Expression, In Vitro, Purification, and 18 others.
Current workplace
Christopher Bond's current company
Company context helps verify the profile and gives searchers a useful next step.
11 roles · 31 years
Christopher Bond work experience
A career timeline built from the work history available for this profile.
Svp Research And Early Development
Current
Nov 2021 - Present
Svp Pre-Clinical And Translational Sciences
Jan 2021 - Nov 2021
Vp Cellular Engineering
May 2019 - Jan 2021
Senior Director Lead Discovery
Head of pipeline development group responsibilities include:CAR and TCR discovery and developmentCRISPR gene engineering and cellular engineering Cell and Protein Science departmentsSenior Research Liaison with Editas MedicineChair Juno Leadership Council - 2017
Apr 2016 - Aug 2018
Head Biologics
The Centre For Drug Research And Development
- Lead therapeutic antibody discovery and immunotherapy programs.
- Responsible for antibody technology platforms including; bispecific antibodies, HLA tumor antigens, and antigen specific T-cell targeting strategies.
- Lead hybridoma, B-cell based discovery platforms and functional screening teams.
- Oversee all aspects of antibody discovery and development including; antigen expression and purification, antibody discovery, V-gene cloning, affinity maturation, epitope mapping, humanization, research scale.
- Joint lead Bioanalytical team.
- Research liaison with academic collaborators for all therapeutic antibody, biologics and immunotherapy programs.
Apr 2014 - Apr 2016
Director Antibody Engineering
- Invented mammalian antibody display platform.
- Key inventor and lead scientist on a bi-specific antibody targeting VEGF and DLL4.
- Led discovery of Rspondin3 mAb which along with VEGF-DLL4 bispecific are now partnered with Celgene.
2008 - Mar 2014
2007 - 2008
~1 yr
Postdoctoral Fellow
- Led investigations into the structural basis of antigen recognition and presentation in the adaptive immune system.
- Engineered T-Cell receptor constructs for phage display.
- Led combinatorial biology group in lab of K. Christopher Garcia at Stanford University.
- Advised students on theory and practice of phage display.
2005 - 2007
~2 yrs
Postdoctoral Fellow
- Designed stable stand-alone single domain antibody scaffolds.
- Invented library and sequencing based technique for the quantification of protein stability determinants in antibodies.
- Developed structure based database of antibody diversity.
- Developed method for the high throughput generation of soluble protein from phage display libraries.
2000 - 2004
~4 yrs
Graduate Student
Fred Hutchinson Cancer Research Center
1995 - 2000
~5 yrs
2 education records
Christopher Bond education
Ph.D., Biochemistry
University Of Washington
Bachelor Of Science (Bs), Physics
The Evergreen State College
FAQ
Frequently asked questions about Christopher Bond
Quick answers generated from the profile data available on this page.
What company does Christopher Bond work for?
Christopher Bond works for Notch Therapeutics.
What is Christopher Bond's role at Notch Therapeutics?
Christopher Bond is listed as CSO at Notch Therapeutics at Notch Therapeutics.
What is Christopher Bond's email address?
AeroLeads has found 1 work email signal at @notchtx.com for Christopher Bond at Notch Therapeutics.
Where is Christopher Bond based?
Christopher Bond is based in Seattle, Washington, United States while working with Notch Therapeutics.
What companies has Christopher Bond worked for?
Christopher Bond has worked for Notch Therapeutics, Kite Pharma, Juno Therapeutics, Inc., The Centre For Drug Research And Development, and Oncomed Pharmaceuticals.
How can I contact Christopher Bond?
You can use AeroLeads to view verified contact signals for Christopher Bond at Notch Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Christopher Bond attend?
Christopher Bond holds Ph.D., Biochemistry from University Of Washington.
What skills is Christopher Bond known for?
Christopher Bond is listed with skills including Antibodies, Protein Expression, In Vitro, Purification, Elisa, Protein Chemistry, Cell Culture, and Biochemistry.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial